SK chemicals

*unit : Million won

Consolidated balance sheet
	5th period (2021)	4th period (2020)	3rd period (2019)
Assets ▼
I. Current assets:	2,784,059	923,286	792,023
(1) Liquid Assets	2,434,759	670,356	461,417
(2) Inventory	349,299	252,930	330,606
II. Noncurrent assets:	1,171,574	1,196,681	1,339,686
(1) Investment in related company and joint venture	16,328	9,104	8,776
(2) Tangible assets	999,246	1,070,000	1,165,065
(3) Intangible assets	44,422	36,956	37,429
(4) Other non-current assets	111,577	80,621	128,416
Total assets:	3,955,632	2,119,967	2,131,709
Liabilities ▼
I. Current liabilities:	1,086,649	645,679	718,865
II. Non-current liabilities:	302,246	515,355	694,137
Total Liaiblities:	1,388,895	1,161,034	1,413,003
Equity ▼
I. Controlling interest	2,053,542	952,878	715,629
Issued capital	98,681	66,000	66,000
capital surplus	1,192,769	264,315	264,315
Other capital adjustments	-21,346	-18,118	-9,890
Accumulated other comprehensive income	2,937	-2,624	-2,594
Retained earnings	780,501	643,305	397,797
II. Non-controlling interest	513,196	6,055	3,078
Total Equity:	2,566,737	958,933	718,706
Total Liabilities and Equity:	3,955,632	2,119,967	2,131,709

*unit : Million won

Consolidated income statement
	5th period (2021)	4th period (2020)	3rd period (2019)
I. Sales	2,089,632	1,198,781	1,112,919
II. Cost of sales	1,208,252	810,783	841,892
III. Gross profits	881,380	387,998	271,027
IV. Selling, General Administrative Expenses	326,194	232,640	229,794
V. Operating Income	555,186	155,358	41,233
VI. Other Income	27,410	12,568	9,266
VII. Other expenses	44,231	27,815	38,385
VIII. Financial income	62,589	44,135	25,985
IX. Financial costs	63,950	60,131	54,255
X. Income from Investments in Associates	1,619	1,757	2,042
XI. Profit (loss) before income tax from continued operations	538,622	125,872	-14,114
XII. Income tax expense (benefit) from continued operations	168,012	35,924	8,882
XIII. Income from Continuing Operations	370,610	89,947	-22,996
XIV. Income from discontinued Operations	-101,866	165,214	28,018
XV. Consolidated net income	268,743	255,161	5,022

*unit : Million won

Balance sheet
	5th period (2021)	4th period (2020)	3rd period (2019)
Assets ▼
I. Current assets:	850,385	542,387	583,836
(1) Liquid Assets	673,715	390,369	324,388
(2) Inventory	176,670	152,018	259,448
II. Non-current assets:	1,136,764	1,202,198	1,318,635
(1) Investment in related company and joint venture	13,176	5,091	5,091
(2) Investment in subsidiaries	369,310	248,206	224,280
(3) Tangible assets	663,485	878,396	969,586
(4) Intangible assets	25,582	18,815	17,609
(5) Other non-current assets	65,212	51,690	102,069
Total Assets:	1,987,150	1,744,585	1,902,472
Liabilities ▼
I. Current liabilities:	608,416	461,441	654,993
II. Non-current liabilities:	223,150	398,071	563,035
Total liabilities:	831,566	859,511	1,218,028
Equity ▼
I. Issued capital:	98,681	66,000	66,000
II. Capital surplus:	155,974	188,347	188,347
III. Other capital adjustments:	-12,345	-9,117	-889
IV. Retained earnings:	913,274	639,843	430,985
Total Equity:	1,155,584	885,073	684,444
Total Liabilities and Equity:	1,987,150	1,744,585	1,902,472

*unit : Million won

Income statement
	5th period (2021)	4th period (2020)	3rd period (2019)
I. Sales	1,093,357	905,275	869,939
II. Cost of sales	829,073	652,902	665,368
III. Gross profits	264,284	252,373	204,572
IV. Selling, General Administrative Expenes	181,991	154,678	152,094
V. Operating Income	82,293	97,695	52,477
VI. Other Income	488,793	11,262	9,541
VII. Other expenses	41,363	21,232	36,209
VIII. Financial income	43,398	40,542	23,109
IX. Financial costs	32,235	49,433	39,877
X. Profit (loss) before income tax from continued operations	540,885	78,834	9,040
XI. Income tax expense (benefit) from continued operations	136,417	28,087	9,961
XII. Profit for the year from continuing operations	404,468	50,747	-921
XIII. Profit for the year from discontinuing operations (net of tax)	-101,965	164,996	28,018
XIV. Net income	302,503	215,743	27,097

ESG 메뉴